Ting Dai

Corporate Officer/Principal en Zensun (Shanghai) Sci & Tech Co., Ltd. .

45 años

Consumer Services

Health Technology

Perfil

Ting Dai currently works at Zensun (Shanghai) Sci & Tech Co., Ltd., as Deputy General Manager from 2019.
Ms. Dai received her graduate degree in 2016 from Shanghai University of Finance & Economics, Masters Business Admin degree from Shanghai University of Finance & Economics, and undergraduate degree in 2001 from Anhui Science & Technology University.

Cargos activos de Ting Dai

Empresas	Cargo	Inicio
Zensun (Shanghai) Sci & Tech Co., Ltd. Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China.	Corporate Officer/Principal	21/02/2019

Todos los cargos activos de Ting Dai

Formación de Ting Dai.

Shanghai University of Finance & Economics	Masters Business Admin
Anhui Science & Technology University	Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Ting Dai.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
Zensun (Shanghai) Sci & Tech Co., Ltd. Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China.	Health Technology